Skip to main content
SpringerLink
Log in

Diagnosis and Management of Precancerous Cervical Lesions

  • Management of HPV and Associated Cervical Lesions (C-H Lai, Section Editor)
  • Published:
Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Over the past five decades, the Pap smear for cervical cancer screening has become standard of care across the United States and other countries, and its implementation in the routine gynecologic examination has dramatically reduced the rates of invasive cervical cancer. As we have come to understand the nuances of this routine screening and are increasingly better able to identify precancerous cervical lesions, we have also developed improved screening and treatment modalities. This progress has led to ever-changing diagnostic and management guidelines. Over the last several years, the American Society for Colposcopy and Cervical Pathology (ASCCP) has revised its guidelines for cervical cancer screening and issued new recommendations for treatment and management of cervical dysplasia. In addition, investigators across the world are exploring improved methods of screening, treatment, and identification of precancerous cervical lesions. Such methods include optimizing HPV testing, genotyping HPV and identifying associations with cervical dysplasia, and optimizing the timing and efficacy of treatment. This article will review and critically evaluate the literature published within the past year with regard to the diagnosis and management of precancerous cervical lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Barakat RR, Berchuck A, Markman M, Randall M. Principles and practice of gynecologic oncology. 6th ed. Philadelphia: Lippincott, Williams, and Wilkins; 2013.

    Google Scholar 

  2. Peralta-Zaragoza O, et al. HPV-based screening, triage, treatment, and follow-up strategies in the management of cervical intraepithelial neoplasia. Obstet Gynecol Int. 2013.

  3. Lentz M, Lobo RA, et al. Comprehensive gynecology. 6th ed. Philadelphia: Elsevier Mosby; 2012.

    Google Scholar 

  4. Shetty MK. Breast and gynecologic cancers: an integrated approach for screening and diagnosis in developing countries. New York: Springer Sciences; 2013. p. 83–98.

    Book  Google Scholar 

  5. D’Ottaviano M, et al. HPV 16 is related to the progression of cervical intraepithelial neoplasia grade 2: a case series. Obstet Gynecol Int. 2013.

  6. Tornesello M, et al. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. BioMed Res Int. 2013.

  7. Broccolo F, Fusetti L, et al. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study. J Med Virol. 2013;85:472–82.

    Article  CAS  PubMed  Google Scholar 

  8. Luhn P et al. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2012;128:265–70.

    Article  PubMed  Google Scholar 

  9. Vessey M, Yeates D. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association Contraceptive Study. Contraception. 2013;88:678–83.

    Article  CAS  PubMed  Google Scholar 

  10. Gierisch J, Coeytaux RR, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013;22:1931–43.

    Article  PubMed  Google Scholar 

  11. Stewart ML et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121(4):829–46. A concise overview of the updated 2012 ASCCP guidelines organized by abnormal cytology and histologic diagnosis.

    Google Scholar 

  12. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol. 2013;122(6):1338–66.

  13. Nanda K, McCrory DC, et al. Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132(10):810–9.

    Article  CAS  PubMed  Google Scholar 

  14. Guo M, Gong Y, et al. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal papanicolaou results. Cancer Cytopathol. 2012.

  15. Rao A et al. Comparison of hybrid capture 2 high-risk HPV results in the low positive range with cobas HPV test results from the ATHENA study. J Clin Virol. 2013;58:161–7.

    Article  PubMed  Google Scholar 

  16. Gillo-Tos A, De Marco L, et al. Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study. J Clin Microbiol. 2013;51(9):2901–7.

    Article  Google Scholar 

  17. Moberg M, Gustavsson I, et al. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk cervical cancer. J Clin Microbiol. 2003;41(7):3221–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Perez-Castro S et al. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA. J Med Virol. 2013;85:1063–8.

    Article  PubMed  Google Scholar 

  19. Oliveira A, Verdasca N, Pista Â. Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia. J Med Virol. 2013;85:1235–41.

    Article  CAS  PubMed  Google Scholar 

  20. Giuseppe V et al. Validity of the colposcopic criteria inner border sign, ridge sign, and rag sign for detection of high-grade cervical intraepithelial neoplasia. Obstet Gynecol. 2013;121(3):624–33. This study attempts to standardize colposcopic evaluation and decrease the subjectivity of colposcopy by introducing three signs that are not graded, but rather either present or absent, in cases of cervical neoplasia.

    Google Scholar 

  21. Apgar B et al. Gynecologic procedures: colposcopy, treatment of cervical intraepithelial neoplasia, and endometrial assessment. Am Fam Physician. 2013;87(12):836–43.

    PubMed  Google Scholar 

  22. Mandic A et al. Comparison the histopathological findings after cervical biopsy and excisional procedures. Acta Med. 2013;56(1):19–22.

    Google Scholar 

  23. Carozzi F et al. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomized controlled trial. Lancet Oncol. 2013;14:168–76.

    Article  PubMed  Google Scholar 

  24. Wei Q et al. Combined detection of p16ink4a and IMP2 increase the concordance rate between cervical cytologic and histologic diagnosis. Int J Clin Exp Pathol. 2013;6(8):1549–57.

    PubMed Central  PubMed  Google Scholar 

  25. Martin-Hirsch PP, et al. Surgery for cervical intraepithelial neoplasia (Review). Cochrane Database. 2013. An extensive review and comparison of all ablative and excisional treatment options for precancerous cervical lesions.

  26. Long S, Leeman L. Treatment options for high-grade squamous intraepithelial lesions. Obstet Gynecol Clin N Am. 2013;40(2):291–316.

    Article  Google Scholar 

  27. Le T, El-Sugi W, et al. Loop electrosurgical excision procedure for the treatment of cervical intraepithelial neoplasia: how much excision is enough? J Obstet Gynaecol. 2013;33:622–5.

    Article  CAS  PubMed  Google Scholar 

  28. DeCaw A, Hadler J, et al. The prevalence of HPV associated cervical intraepithelial neoplasia in women under age 21: who will be missed under the new cervical cancer screening guidelines? J Pediatr Adolesc Gynecol. 2013;26(6):346–9.

    Article  Google Scholar 

  29. Garrett L, McCann C. Abnormal cytology in 2012: management of atypical squamous cells, low-grade intraepithelial neoplasia, and high-grade intraepithelial neoplasia. Clin Obstet Gynecol. 2013;56(1):25–34.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Melinda S. Auer declares that she has no conflict of interest.

David G. Mutch has received grants from NIH, NCI, Lilly, and Genentech.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Melinda S. Auer

  2. Judith and Ira Gall Professor of Gynecologic Oncology, Division of Gynecologic Oncology, Washington University School of Medicine, 4911 Barnes-Jewish Hospital Plaza, St. Louis, MO, 63110, USA

    David G. Mutch

Authors
  1. Melinda S. Auer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David G. Mutch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David G. Mutch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Auer, M.S., Mutch, D.G. Diagnosis and Management of Precancerous Cervical Lesions. Curr Obstet Gynecol Rep 3, 128–135 (2014). https://doi.org/10.1007/s13669-014-0083-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-014-0083-x

Keywords

Search

Navigation